1. COVID-19 threatens M&A already in process— Physician survey shows widespread concern about access to testing and medical supplies for COVID— Novartis cancels $1B generics sale — See more on our front page news Stay updated with the latest pharma-related coronavirus news on our new page
    Dismiss Notice
  2. Think you have witnessed fraud?Ask a Whistleblower Attorney -- a chance to discuss whistleblower-related legal issues with practicing whistleblower attorneys.
    Dismiss Notice

77 Deaths in FDA Serious Case Update

Discussion in 'Neurocrine' started by anonymous, Nov 19, 2018 at 3:20 PM.

Tags: Add Tags
  1. anonymous

    anonymous Guest


  2. anonymous

    anonymous Guest

    Ok what the heck is going on here. I’m about to accept an offer but this sounds like a serious red flag.
     
  3. anonymous

    anonymous Guest

    Read deeper. It does not link deaths to a drug... consider death by another cause while happening to take a drug.
     
  4. anonymous

    anonymous Guest

    Ingrezza's PI lists severe reactions and hospitalizations! The drug is hospitalizing people!
     
  5. anonymous

    anonymous Guest

    This is not good, people.
     
  6. anonymous

    anonymous Guest

    According to my psychs, Neurocrine is back to lying about Austedo again. They know we don't have a black box for suicidal ideation or behavior in the Tardive population. We have already debunked your lies with facts/proof and our MSLs. They know you people lie and they talk about it. If one more provider tells me you are peddling this blatant lie again, a formal complaint will be lodged against the company and the rep.
     
  7. anonymous

    anonymous Guest

    We don’t need to lie about your drug. It’s a second line product and numbers and market share show it. Majority of your RX is because you have preferred coverage bc your company bent over at the negotiating table. Also, didn’t a large group of reps and managers just get fired from Teva for shady sales tactics? Pot calling the kettle?
     
  8. anonymous

    anonymous Guest

    You guys are lying about Austedo daily. You know it. The only supposed benefit you may have is once a day dosing. That's it.
     
  9. anonymous

    anonymous Guest

    I'm surprised Teva reps don't point out some of the more obvious shortcomings and risks
     
  10. anonymous

    anonymous Guest

    I am not comfortable with the hospitalizations this drug has caused.
     
  11. anonymous

    anonymous Guest

    My physicians aren't either. I tried telling them it's a class affect, but they are seeing Parkinsonism with Ingrezza way too much.
     
  12. anonymous

    anonymous Guest

    My speaker is very upset about this PI change. He has read the fine print about severity and hospitalizations.
     
  13. anonymous

    anonymous Guest

    Bigger market for opicapone?
     
  14. anonymous

    anonymous Guest

    UPDATE!!!!!
    205 deaths
     
  15. anonymous

    anonymous Guest

    whats a few deaths! Think of all the people we are helping! Also, we have our profits to consider. Ssshhhhh! Keep all of this on the down low!